BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 25606692)

  • 1. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
    Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
    Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
    Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
    Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
    Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertension.
    Derrett-Smith EC; Dooley A; Gilbane AJ; Trinder SL; Khan K; Baliga R; Holmes AM; Hobbs AJ; Abraham D; Denton CP
    Arthritis Rheum; 2013 Nov; 65(11):2928-39. PubMed ID: 23839959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
    Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
    Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis.
    Xu B; Xu G; Yu Y; Lin J
    Arthritis Res Ther; 2021 Nov; 23(1):288. PubMed ID: 34819148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
    Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
    Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?
    Morrell NW
    Proc Am Thorac Soc; 2006 Nov; 3(8):680-6. PubMed ID: 17065373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
    Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
    Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells.
    Mair KM; Yang XD; Long L; White K; Wallace E; Ewart MA; Docherty CK; Morrell NW; MacLean MR
    Am J Respir Crit Care Med; 2015 Mar; 191(6):693-703. PubMed ID: 25608111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta/bone morphogenic protein signaling in pulmonary arterial hypertension: remodeling revisited.
    Eickelberg O; Morty RE
    Trends Cardiovasc Med; 2007 Nov; 17(8):263-9. PubMed ID: 18021936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary arterial hypertension and BMP system abnormality].
    Otsuka F
    Nihon Rinsho; 2008 Nov; 66(11):2083-90. PubMed ID: 19051724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
    Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension.
    Meadows CA; Risbano MG; Zhang L; Geraci MW; Tuder RM; Collier DH; Bull TM
    Chest; 2011 May; 139(5):994-1002. PubMed ID: 20829333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
    Feng F; Harper RL; Reynolds PN
    Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.
    Upton PD; Morrell NW
    Exp Physiol; 2013 Aug; 98(8):1262-6. PubMed ID: 23645549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood.
    Harrison RE; Berger R; Haworth SG; Tulloh R; Mache CJ; Morrell NW; Aldred MA; Trembath RC
    Circulation; 2005 Feb; 111(4):435-41. PubMed ID: 15687131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.